Pelareorep to promote the expression of a IFN-gamma-related gene signature that predicts response to checkpoint blockade therapy.

被引：0
|
作者：
Wilkinson, Grey A.
Piar, Aine
Resnyk, Christopher
Humphrey, M. Jordan
Glendinning, Keith
Hue Tran
Chakrabarty, Romit
Gutierrez, Andres
Coffey, Matthew C.
机构：
[1] Oncolyt Biotech Inc, Calgary, AB, Canada
[2] Almac, Durham, NC USA
[3] Oncolyt Biotech, Calgary, AB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.3089
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3089
引用
收藏
页数：1
相关论文
共 23 条
  • [21] INTERFERON-GAMMA GENE-EXPRESSION IN UNSTIMULATED BONE-MARROW MONONUCLEAR-CELLS PREDICTS A GOOD RESPONSE TO CYCLOSPORINE THERAPY IN APLASTIC-ANEMIA
    NAKAO, S
    YAMAGUCHI, M
    SHIOBARA, S
    YOKOI, T
    MIYAWAKI, T
    TANIGUCHI, T
    MATSUDA, T
    BLOOD, 1992, 79 (10) : 2532 - 2535
  • [22] LBH589, a novel histone deacetylase inhibitor (HDACi), treatment of patients with cutaneous T-cell lymphoma (CTCL). Changes in skin gene expression profiles related to clinical response following therapy.
    Prince, H. M.
    George, D. J.
    Johnstone, R.
    Williams-Truax, R.
    Atadja, P.
    Zhao, C.
    Dugan, M.
    Culver, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 422S - 422S
  • [23] LBH589, a novel deacetylase inhibitor (DACi), treatment of patients with cutaneous T-cell lymphoma (CTCL). Skin gene expression profiles in the first 24 hours related to clinical response following therapy.
    Prince, Miles
    George, D. J.
    Johnstone, R.
    McCormack, C.
    Ellis, L.
    Williams-Truax, R.
    Atadja, P.
    Zhao, C.
    Dugan, M.
    Culver, K.
    BLOOD, 2006, 108 (11) : 767A - 767A
123